Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

"Leveraging the response to COVID-19 to reinforce investments in a system-based approach to address these risks can boost proactive recovery and resilience. " Abiodun Awosusi (cohort 2016-17) and Marius Adeniyi

Africa satellite image © google maps

Our alumni Abiodun Awosusi (cohort 2016-17) and Marius Adeniyi highlight key response efforts to COVID-19 across Africa and propose guiding principles for a sustained response, recovery and resilience. 

Read the article: COVID-19: Charting a sustainable path to response, recovery and resilience in Africa on the IHP website

Similar stories

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Sandra Adele (cohort 2019-2020) co-authored this paper assessing the benefits of interval extension between BNT162b2 mRNA vaccine doses.

Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocol

Simon Mendelsohn (cohort 2015-16) co-authored this systematic review protocol on the current triage and predictive tools and how host tuberculosis transcriptomic biomarkers may be more effective for a correct diagnosis.

Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis

Simon Mendelsohn (cohort 2015-16) co-authored this article.

Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20–22 April 2021

Simon Mendelsohn (cohort 2015-16) co-authored this article on the Global Forum on Tuberculosis (TB) Vaccines and how this year's event focussed on opportunities and challenges for TB vaccine R&D during a pandemic.

Delays in presentation of intussusception and development of gangrene in Zimbabwe

Student Dennis Mazingi (cohort 2020-2021) co-authored this paper focused on the importance of a prompt diagnosis and treatment of intussusception in Zimbabwe. Their findings highlight the need to improve early diagnosis of intussusception and prompt referral of patients for treatment.

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial

Sandra Adele (cohort 2019-2020) co-authored this paper on the efficacy of the Oxford Astra-Zeneca vaccine for the 40 million people globally living with HIV. This study aimed to assess the vaccine’s ability to stimulate an immune response on those who have their immunity compromised.